Original Research

Seroprevalence and associated risk factors of Rift Valley fever in cattle and selected wildlife species at the livestock/wildlife interface areas of Gonarezhou National Park, Zimbabwe

Masimba Ndengu, Gift Matope, Musavengana Tivapasi, Davies M. Pfukenyi, Catherine Cetre-Sossah, Michel de Garine-Wichatitsky
Onderstepoort Journal of Veterinary Research | Vol 87, No 1 | a1731 | DOI: https://doi.org/10.4102/ojvr.v87i1.1731 | © 2020 Masimba Ndengu, Gift Matope, Musavengana Tivapasi, Davies M. Pfukenyi, Catherine Cetre-Sossah, Michel de Garine-Wichatitsky | This work is licensed under CC Attribution 4.0
Submitted: 24 January 2019 | Published: 08 April 2020

About the author(s)

Masimba Ndengu, Department of Clinical Veterinary Studies, Faculty of Veterinary Science, University of Zimbabwe, Harare, Zimbabwe
Gift Matope, Department of Paraclinical Veterinary Studies, Faculty of Veterinary Science, University of Zimbabwe, Harare, Zimbabwe
Musavengana Tivapasi, Department of Clinical Veterinary Studies, Faculty of Veterinary Science, University of Zimbabwe, Harare, Zimbabwe
Davies M. Pfukenyi, Department of Clinical Veterinary Studies, Faculty of Veterinary Science, University of Zimbabwe, Harare, Zimbabwe
Catherine Cetre-Sossah, CIRAD, UMR ASTRE Animal Santé Territoires Risques Ecosystemes 2, Rue Maxime Rivière, Réunion, France
Michel de Garine-Wichatitsky, UR AGIRs, Cirad, Campus International de Baillarguet, Montpellier, France

Abstract

A study was conducted to investigate the seroprevalence and associated risk factors of Rift Valley fever (RVF) infection in cattle and some selected wildlife species at selected interface areas at the periphery of the Great Limpopo Transfrontier Conservation Area in Zimbabwe. Three study sites were selected based on the type of livestock–wildlife interface: porous livestock–wildlife interface (unrestricted); non-porous livestock–wildlife interface (restricted by fencing) and livestock–wildlife non-interface (totally absent contact or control). Sera were collected from cattle aged ≥ 2 years representing both female and intact male. Sera were also collected from selected wild ungulates from Mabalauta (porous interface) and Chipinda Pools (non-interface) areas of the Gonarezhou National Park. Sera were tested for antibodies to Rift Valley fever virus (RVFV) using a competitive enzyme-linked immunosorbent assay (ELISA) test. AX2 test was used to assess differences between categories, and p < 0.05 was considered as significant. In cattle, the overall seroprevalence was 1.7% (17/1011) (95% confidence interval [CI]: 1.01–2.7). The porous interface recorded a seroprevalence of 2.3% (95% CI: 1.2–4.3), the non-porous interface recorded a prevalence of 1.8% (95% CI: 0.7–4.3) and the non-interface area recorded a seroprevalence of 0.4% (955 CI: 0.02–2.5), but the difference in seroprevalence according to site was not significant (p > 0.05). All impala and kudu samples tested negative. The overall seroprevalence in buffaloes was 11.7% (95% CI: 6.6–19.5), and there was no significant (p = 0.38) difference between the sites (Mabalauta, 4.4% [95% CI: 0.2–24] vs. Chipinda, 13.6% [95% CI: 7.6–23]). The overall seroprevalence in buffaloes (11.7%, 13/111) was significantly (p < 0.0001) higher than in cattle (1.7%, 17/1011). The results established the presence of RVFV in cattle and selected wildlife and that sylvatic infections may be present in buffalo populations. Further studies are required to investigate if the virus is circulating between cattle and wildlife.

Keywords

Rift Valley fever; abortion; zoonosis; cattle; wildlife

Metrics

Total abstract views: 5628
Total article views: 4941

 

Crossref Citations

1. Evidence of co-exposure with Brucella spp, Coxiella burnetii, and Rift Valley fever virus among various species of wildlife in Kenya
Francis Gakuya, James Akoko, Lillian Wambua, Richard Nyamota, Bernard Ronoh, Isaac Lekolool, Athman Mwatondo, Mathew Muturi, Collins Ouma, Daniel Nthiwa, Earl Middlebrook, Jeanne Fair, John Gachohi, Kariuki Njenga, Bernard Bett, Ana LTO Nascimento
PLOS Neglected Tropical Diseases  vol: 16  issue: 8  first page: e0010596  year: 2022  
doi: 10.1371/journal.pntd.0010596

2. Sero-prevalence of West Nile virus and Rift Valley fever virus infections among cattle under extensive production system in South Omo area, southern Ethiopia
Adugna Endale, Daniela Michlmayr, Woldaregay Erku Abegaz, Bayilla Geda, Getahun Asebe, Girmay Medhin, James W. Larrick, Mengistu Legesse
Tropical Animal Health and Production  vol: 53  issue: 1  year: 2021  
doi: 10.1007/s11250-020-02506-0

3. Mapping the risk of Rift Valley fever in Uganda using national seroprevalence data from cattle, sheep and goats
Dan Tumusiime, Emmanuel Isingoma, Optato B. Tashoroora, Deo B. Ndumu, Milton Bahati, Noelina Nantima, Denis Rwabiita Mugizi, Christine Jost, Bernard Bett, Nigel Beebe
PLOS Neglected Tropical Diseases  vol: 17  issue: 5  first page: e0010482  year: 2023  
doi: 10.1371/journal.pntd.0010482

4. Preferred livestock interventions for small-scale farmers in the Great Limpopo Transfrontier Conservation Area: a demand-driven and participatory approach
Vimbai Gobvu, Sharai Ncube, Venancio E. Imbayarwo-Chikosi, Robin Bourgeois, Prisca H. Mugabe, Alexandre Caron
Peer Community Journal  vol: 5  year: 2025  
doi: 10.24072/pcjournal.525

5. Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021
Keli N. Gerken, A. Desirée LaBeaud, Henshaw Mandi, Maïna L’Azou Jackson, J. Gabrielle Breugelmans, Charles H. King, Eric Mossel
PLOS Neglected Tropical Diseases  vol: 16  issue: 1  first page: e0009852  year: 2022  
doi: 10.1371/journal.pntd.0009852

6. External quality assessment of Rift Valley fever diagnosis in countries at risk of the disease: African, Indian Ocean and Middle-East regions
Aurélie Pedarrieu, Fatiha El Mellouli, Hanane Khallouki, Khalil Zro, Ghizlane Sebbar, Soufien Sghaier, Hafsa Madani, Nadera Bouayed, Modou Moustapha Lo, Mariame Diop, Ahmed Bezeid Ould El Mamy, Yahya Barry, Marthin Dakouo, Abdallah Traore, Haladou Gagara, Maman Moutari Souley, Sara Acha, Laurenco Mapaco, Jelly Chang’a, Denis Nyakilinga, Baratang A. Lubisi, Thabisile Tshabalala, Claudia Filippone, Jean Michel Heraud, Sitty-Bahyat Chamassy, Abdou Achiraffi, Nicolas Keck, Gilda Grard, Kareem Abdelfattah Abdelwahab Mohammed, Abdulwahed Mohammed Alrizqi, Catherine Cetre-Sossah, Pierre Roques
PLOS ONE  vol: 16  issue: 5  first page: e0251263  year: 2021  
doi: 10.1371/journal.pone.0251263

7. First detection of Rift Valley fever virus antibodies in non‐human primates in Cameroon
Jean Thierry Ebogo‐Belobo, Serge Alain Sadeuh‐Mba, Gwladys Monamele Chavely, Martin H. Groschup, Wilfred Fon Mbacham, Richard Njouom
Journal of Medical Primatology  vol: 53  issue: 1  year: 2024  
doi: 10.1111/jmp.12687

8. Evidence of human exposure and associated risk factors to Rift Valley fever in selected districts of Central and Western Zambia
Chilufya C. Kasongamulilo, Michelo Syakalima, Ngondo Saasa, Henson Kainga, Girja S. Pandey, Andrew N. Mukubesa, Innocent Mwape, Masahiro Kajihara, Ayato Takada, Martin Simuunza, James Colborn
PLOS ONE  vol: 20  issue: 1  first page: e0309288  year: 2025  
doi: 10.1371/journal.pone.0309288

9. Rift Valley fever epidemiology: shifting the paradigm and rethinking research priorities
Melinda K Rostal, Peter N Thompson, Assaf Anyamba, Bernard Bett, Catherine Cêtre-Sossah, Véronique Chevalier, Milehna Guarido, William B Karesh, Alan Kemp, A Desiree LaBeaud, Alison Lubisi, Louise Matthews, Veerle Msimang, M Kariuki Njenga, Noam Ross, Dan Tumusiime, William C Wilson, Jacqueline Weyer, Janusz T Paweska, Robert Swanepoel
The Lancet Planetary Health  vol: 9  issue: 9  first page: 101299  year: 2025  
doi: 10.1016/j.lanplh.2025.101299